Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01848951 · ClinicalTrials.gov registry record

Comparison of Epidural and TAP Block in Abdominal Surgery

A clinical trial of Surgery and Acute Pain, sponsored by University of Nebraska.

Completed
Registry status
72
Enrollment target
1
Study location

NCT01848951 is a study of Surgery and Acute Pain that has completed, run by University of Nebraska. The registered enrollment target is 72 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01848951, a study of Surgery and Acute Pain, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
72 participants
Enrollment target
1
Study location

Study Summary

This study will compare the infiltrative transversusabdominis plane (TAP) block with liposomal bupivacaine to epidural analgesia (EA) in major abdominal surgery . The efficacy of the TAP block for abdominal surgery is well documented in literature, but there are no studies utilizing long-acting bupivacaine. The investigators believe the study will demonstrate no difference between the two in terms of pain scores and opioid consumption, but TAP blocks will decreased costs, urinary retention, and hypotension.

Interventions

  • DRUG Epidural
  • DRUG TAP Block

Study Locations (1)

Nebraska

  • University of Nebraska Medical Center - Omaha

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2014-02-01
Est. Completion 2016-12-01

Sponsor

University of Nebraska

407 total trials

What the Registry Record Tells You About NCT01848951

The ClinicalTrials.gov registry entry for NCT01848951 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Epidural is the first listed.

NCT01848951 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT01848951 about?

NCT01848951 is a clinical study titled "Comparison of Epidural and TAP Block in Abdominal Surgery". This study will compare the infiltrative transversusabdominis plane (TAP) block with liposomal bupivacaine to epidural analgesia (EA) in major abdominal surgery . The efficacy of the TAP block for abdominal surgery is well documented in literature, but there are no studies utilizing long-acting bupi...

What is the current status of trial NCT01848951?

This trial is currently completed. The enrollment target is 72 participants. The study started on 2014-02-01. Estimated completion is 2016-12-01.

What conditions does trial NCT01848951 study?

This clinical trial studies the following conditions: Surgery, Acute Pain, Regional Anesthesia.

What interventions are being tested in trial NCT01848951?

The interventions under investigation include: Epidural (DRUG), TAP Block (DRUG).

Who is sponsoring clinical trial NCT01848951?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01848951 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.